查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1427923

2024 年神经毒素全球市场报告

Neurotoxin Global Market Report 2024
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10个工作天内

价格
简介目录

神经毒素的市场规模预计在未来几年将快速成长。预计到 2028 年将以 10.7% 的复合年增长率 (CAGR) 增长至 111.4 亿美元。预测期内的预期增长可归因于神经学应用的扩大、美容手术的持续需求、配方创新、消费者意识的提高以及美容旅游的扩张。预测期内预计的显着趋势包括药物输送技术的进步、神经毒素开发和研究的合作、市场对神经毒素行业监管变化的反应以及对多学科治疗计划的紧张情绪。持久效果和患者满意度。

神经毒素市场的预期成长预计将受到旨在改善外观的整容手术的普及推动。整容手术包括各种医疗干预措施，其主要目的是改善或改变个人的外观。这一趋势受到社会、技术和文化因素的影响，再加上人们对整容手术的好处的认识不断提高。神经毒素在这些过程中发挥着重要作用，它可以放鬆某些肌肉，从而减少皱纹和细纹的出现。例如，在2022年8月美国整形外科医生协会关于整容手术的调查中，四分之三的美国整形外科医生指出需求增加，30%的人表示整容手术的需求增加了一倍。他们的整容手术业务。为了改善外表而进行的整容手术的激增是推动神经毒素市场成长的关键驱动力。

随着人口老化，神经毒素市场预计将扩大。术语「人口老化」是指以社会或人口中老年人比例增加为特征的人口趋势。随着年龄的增长，我们经常转向基于神经毒素的治疗方法（例如肉毒桿菌）来解决与老龄化相关的美容问题，例如皱纹和脸部皱纹。这一人群正在寻求非侵入性的解决方案来改善他们的外表并实现更年轻和焕发活力的美学。据世界卫生组织 (WHO) 称，全球 60 岁及以上人口正在迅速增加，预计到 2050 年将翻一番，达到 21 亿。因此，人口老化的加剧是推动神经毒素市场成长的关键因素。

目录

第一章执行摘要

第二章 市场特点

第三章 市场趋势与策略

第四章宏观经济情景

  • 高通膨对市场的影响
  • 乌克兰与俄罗斯战争对市场的影响
  • COVID-19 对市场的影响

第五章世界市场规模与成长

  • 全球市场驱动因素与限制因素
    • 市场驱动因素
    • 市场限制因素
  • 2018-2023 年全球市场规模表现与成长
  • 全球市场规模预测与成长，2023-2028、2033

第六章市场区隔

  • 全球神经毒素市场，依产品类型细分、实际及预测，2018-2023、2023-2028、2033
  • 肉毒桿菌
  • Dysport
  • 索敏
  • 其他产品
  • 全球神经毒素市场，按应用、实际和预测细分，2018-2023、2023-2028、2033
  • 治疗
  • 美丽
  • 全球神经毒素市场，按最终用户细分，实际和预测，2018-2023、2023-2028、2033
  • 医院
  • 专科诊所
  • 皮肤科诊所
  • 其他最终用户

第 7 章 区域与国家分析

  • 全球神经毒素市场，按地区、绩效和预测，2018-2023、2023-2028、2033
  • 全球神经毒素市场，依国家、绩效及预测，2018-2023、2023-2028、2033

第八章亚太市场

第九章 中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第14章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章 义大利市场

第20章 西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章加拿大市场

第26章 南美洲市场

第27章 巴西市场

第28章 中东市场

第29章 非洲市场

第三十章 竞争形势及公司概况

  • 神经毒素市场竞争形势
  • 神经毒素市场公司概况
    • AbbVie Inc.
    • Galderma Inc.
    • Ipsen SA
    • Daewoong Pharmaceutical Co. Ltd.
    • Supernus Pharmaceuticals

第31章 其他大型创新公司

  • Merz Pharma GmbH &Co KGaA
  • Hugel Inc.
  • Evolus Inc.
  • Medytox Inc.
  • Croma-Pharma GmbH
  • Revance Therapeutics Inc.
  • US WorldMeds
  • Gufic Biosciences Ltd.
  • Hironic Co. Ltd.
  • Allergan
  • List Biological Labs Inc.
  • Lanzhou Institute of Biological Products Co. Ltd.
  • Solstice Neurosciences
  • Sinclair Pharma
  • Vida Aesthetics

第32章竞争基准化分析

第 33 章. 竞争对手仪表板

第三十四章 重大併购

第35章 未来前景与可能性分析

第36章附录

简介目录
Product Code: r13767

A neurotoxin is a substance specifically designed to be toxic to nerve cells (neurons) or the nervous system. These substances operate by inhibiting cellular processes within neurons.

The primary products classified as neurotoxins include well-known brands such as Botox, Dysport, Xeomin, and others. Botox, derived from the bacteria Clostridium botulinum, is a notable neurotoxin used for both cosmetic and medical purposes. It is employed to temporarily reduce the appearance of wrinkles and to treat certain muscular conditions. These neurotoxin products find applications in therapeutic and aesthetic contexts, with end-users ranging from hospitals and specialty clinics to dermatology clinics and other relevant healthcare facilities.

The neurotoxin market research report is one of a series of new reports from The Business Research Company that provides neurotoxin market statistics, including neurotoxin industry global market size, regional shares, competitors with a neurotoxin market share, detailed neurotoxin market segments, market trends and opportunities, and any further data you may need to thrive in the neurotoxin industry. This neurotoxin market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The neurotoxin market size has grown rapidly in recent years. It will grow from $6.74 billion in 2023 to $7.43 billion in 2024 at a compound annual growth rate (CAGR) of 10.2%. The expansion observed in the historical period can be attributed to several factors, including the increase in aesthetic procedures, the growing prevalence of therapeutic applications, advancements in the cosmetic industry, a rising aging population, and the increasing acceptance of non-surgical procedures.

The neurotoxin market size is expected to see rapid growth in the next few years. It will grow to $11.14 billion in 2028 at a compound annual growth rate (CAGR) of 10.7%. The anticipated growth in the forecast period can be attributed to the expanding applications in neurology, sustained demand for aesthetic procedures, innovations in formulations, increasing consumer awareness, and the expansion of cosmetic tourism. Notable trends expected in the forecast period include advancements in drug delivery techniques, collaborations for neurotoxin development and research, market responses to regulatory changes in the neurotoxin industry, the integration of neurotoxins in multimodal treatment plans, and a heightened focus on achieving long-lasting effects and ensuring patient satisfaction.

The anticipated growth in the neurotoxin market is expected to be propelled by the surge in cosmetic procedures aimed at improving appearance. Cosmetic procedures encompass a diverse range of medical interventions undertaken with the primary objective of enhancing or altering an individual's physical appearance. This trend is influenced by societal, technological, and cultural factors, coupled with increased awareness of the benefits associated with cosmetic procedures. Neurotoxins play a crucial role in these procedures by relaxing specific muscles, thereby reducing the appearance of wrinkles and fine lines. For instance, a cosmetic surgery survey by the American Society of Plastic Surgeons in August 2022 revealed a significant increase in demand for cosmetic procedures, with 3 out of 4 plastic surgeons in the USA noting a rise in demand, and 30% reporting a doubling of their cosmetic procedure businesses. This surge in cosmetic procedures to enhance appearance is a key driver fueling the growth of the neurotoxin market.

The growing aging population is expected to contribute to the expansion of the neurotoxin market. The term 'aging population' refers to a demographic trend characterized by an increasing proportion of elderly individuals within a society or population. As individuals age, they often turn to neurotoxin-based treatments, such as Botox, to address age-related cosmetic concerns such as wrinkles and facial lines. This demographic seeks non-invasive solutions to enhance their appearance and achieve a more youthful and rejuvenated aesthetic. According to the World Health Organization (WHO), the global population of people aged 60 years and older is growing rapidly, expected to double by 2050 and reach 2.1 billion. The growing aging population is thus a significant factor driving the growth of the neurotoxin market.

The innovation of facial aesthetic products is a notable trend gaining popularity in the neurotoxins market, with companies actively engaged in developing and introducing novel products to sustain their positions. One example is Evolus Inc., a US-based medical aesthetics company, which received approval from the Australian Therapeutic Goods Administration (TGA) in January 2023 for Nuceiva (prabotulinumtoxinA). Nuceiva is a neurotoxin specifically designed for aesthetic purposes, aiming to temporarily enhance the appearance of moderate glabellar lines in adult patients. By blocking nerve impulses to facial muscles, the product induces muscle relaxation, smoothing wrinkles resulting from facial expressions, squinting, and frowning.

Major companies operating in the neurotoxins market are emphasizing innovative products, including facial gel serums, with the goal of enhancing patient satisfaction. An example is the ready-to-use BoNT-A neuromodulator, a pre-formulated and prepared Botulinum Toxin Type A (BoNT-A) product. This product offers a convenient and standardized solution for healthcare practitioners in cosmetic or therapeutic applications. In September 2022, Entod Pharmaceuticals, an Indian-based pharmaceutical company, launched Vasuki, a facial gel serum based on synthetic tripeptide snake venom neurotoxin. The serum is formulated to gently relax muscle contractions under the skin, potentially reducing the appearance of wrinkles and fine lines.

In August 2021, Merz Pharma GmbH & Co. KGaA, a Germany-based pharmaceutical company in the neurotoxin market, entered into a strategic partnership agreement with Vensica Therapeutics Ltd., an Israel-based urology catheter designing and development company. The collaboration involves the delivery of botulinum neurotoxin A (Xeomin) to the bladder wall using Vensica's innovative ultrasound-assisted delivery catheter for urology applications. This strategic partnership reflects a commitment to advancing treatment options and delivery methods in the urology field through the combination of Merz's neurotoxin expertise and Vensica's innovative catheter technology.

Major companies operating in the neurotoxin market report are AbbVie Inc., Galderma Inc., Ipsen SA, Daewoong Pharmaceutical Co. Ltd., Supernus Pharmaceuticals, Merz Pharma GmbH & Co KGaA, Hugel Inc., Evolus Inc., Medytox Inc., Croma-Pharma GmbH, Revance Therapeutics Inc., US WorldMeds, Gufic Biosciences Ltd., Hironic Co. Ltd., Allergan, List Biological Laboratories, Lanzhou Institute of Biological Products Co. Ltd., Solstice Neurosciences, Sinclair Pharma, Vida Aesthetics, Aquavit Holdings LLC, PharmaResearch Products Co.Ltd., Entod Pharmaceuticals, Object Pharma Inc., Eisai Co. Ltd.

North America was the largest region in the neurotoxin market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neurotoxin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the neurotoxin market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The neurotoxin market consists of sales of lead, ethanol (drinking alcohol), glutamate, nitric oxide, tetanus toxin, and tetrodotoxin. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Neurotoxin Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on neurotoxin market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for neurotoxin ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The neurotoxin market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Product Type: Botox; Dysport; Xeomin; Other Products
  • 2) By Application: Therapeutic; Aesthetic
  • 3) By End User: Hospitals; Specialty Clinics; Dermatology Clinics; Other End Users
  • Companies Mentioned: AbbVie Inc.; Galderma Inc.; Ipsen SA; Daewoong Pharmaceutical Co. Ltd.; Supernus Pharmaceuticals
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Neurotoxin Market Characteristics

3. Neurotoxin Market Trends And Strategies

4. Neurotoxin Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Neurotoxin Market Size and Growth

  • 5.1. Global Neurotoxin Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Neurotoxin Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Neurotoxin Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Neurotoxin Market Segmentation

  • 6.1. Global Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Botox
  • Dysport
  • Xeomin
  • Other Products
  • 6.2. Global Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Therapeutic
  • Aesthetic
  • 6.3. Global Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Specialty Clinics
  • Dermatology Clinics
  • Other End Users

7. Neurotoxin Market Regional And Country Analysis

  • 7.1. Global Neurotoxin Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Neurotoxin Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Neurotoxin Market

  • 8.1. Asia-Pacific Neurotoxin Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Neurotoxin Market

  • 9.1. China Neurotoxin Market Overview
  • 9.2. China Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Neurotoxin Market

  • 10.1. India Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Neurotoxin Market

  • 11.1. Japan Neurotoxin Market Overview
  • 11.2. Japan Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Neurotoxin Market

  • 12.1. Australia Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Neurotoxin Market

  • 13.1. Indonesia Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Neurotoxin Market

  • 14.1. South Korea Neurotoxin Market Overview
  • 14.2. South Korea Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Neurotoxin Market

  • 15.1. Western Europe Neurotoxin Market Overview
  • 15.2. Western Europe Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Neurotoxin Market

  • 16.1. UK Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Neurotoxin Market

  • 17.1. Germany Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Neurotoxin Market

  • 18.1. France Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Neurotoxin Market

  • 19.1. Italy Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Neurotoxin Market

  • 20.1. Spain Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Neurotoxin Market

  • 21.1. Eastern Europe Neurotoxin Market Overview
  • 21.2. Eastern Europe Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Neurotoxin Market

  • 22.1. Russia Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Neurotoxin Market

  • 23.1. North America Neurotoxin Market Overview
  • 23.2. North America Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Neurotoxin Market

  • 24.1. USA Neurotoxin Market Overview
  • 24.2. USA Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Neurotoxin Market

  • 25.1. Canada Neurotoxin Market Overview
  • 25.2. Canada Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Neurotoxin Market

  • 26.1. South America Neurotoxin Market Overview
  • 26.2. South America Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Neurotoxin Market

  • 27.1. Brazil Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Neurotoxin Market

  • 28.1. Middle East Neurotoxin Market Overview
  • 28.2. Middle East Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Neurotoxin Market

  • 29.1. Africa Neurotoxin Market Overview
  • 29.2. Africa Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Neurotoxin Market Competitive Landscape And Company Profiles

  • 30.1. Neurotoxin Market Competitive Landscape
  • 30.2. Neurotoxin Market Company Profiles
    • 30.2.1. AbbVie Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Galderma Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Ipsen SA
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Daewoong Pharmaceutical Co. Ltd.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Supernus Pharmaceuticals
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Neurotoxin Market Other Major And Innovative Companies

  • 31.1. Merz Pharma GmbH & Co KGaA
  • 31.2. Hugel Inc.
  • 31.3. Evolus Inc.
  • 31.4. Medytox Inc.
  • 31.5. Croma-Pharma GmbH
  • 31.6. Revance Therapeutics Inc.
  • 31.7. US WorldMeds
  • 31.8. Gufic Biosciences Ltd.
  • 31.9. Hironic Co. Ltd.
  • 31.10. Allergan
  • 31.11. List Biological Labs Inc.
  • 31.12. Lanzhou Institute of Biological Products Co. Ltd.
  • 31.13. Solstice Neurosciences
  • 31.14. Sinclair Pharma
  • 31.15. Vida Aesthetics

32. Global Neurotoxin Market Competitive Benchmarking

33. Global Neurotoxin Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Neurotoxin Market

35. Neurotoxin Market Future Outlook and Potential Analysis

  • 35.1 Neurotoxin Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Neurotoxin Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Neurotoxin Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer